Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Igm Biosciences Inc (NQ: IGMS )

7.200 -0.210 (-2.83%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 219,365
Open 7.350
Bid (Size) 7.190 (2)
Ask (Size) 7.200 (1)
Prev. Close 7.410
Today's Range 7.040 - 7.430
52wk Range 3.810 - 17.70
Shares Outstanding 25,905,471
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What 5 Analyst Ratings Have To Say About IGM Biosciences
Via Benzinga
IGM Biosciences Announces Refocusing of Sanofi Collaboration
Agreement focuses on immunology/inflammation, aligning with Sanofi’s ongoing commitment to advancing therapies for patients across multiple inflammatory diseases 
From IGM Biosciences, Inc.
Via GlobeNewswire

Performance

YTD
-17.05%
-17.05%
1 Month
-27.42%
-27.42%
3 Month
-30.50%
-30.50%
6 Month
+60.36%
+60.36%
1 Year
-32.27%
-32.27%

More News

Read More
IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
From IGM Biosciences, Inc.
Via GlobeNewswire
Where IGM Biosciences Stands With Analysts
Via Benzinga
What To Know About HC Wainwright & Co.'s Downgrade of IGM Biosciences
Via Benzinga
Analyst Ratings for IGM Biosciences
Via Benzinga
Where IGM Biosciences Stands With Analysts
Via Benzinga
IGMS Stock Earnings: IGM Biosciences Beats EPS, Misses Revenue for Q4 2023
Via InvestorPlace
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
From IGM Biosciences, Inc.
Via GlobeNewswire
CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
RBC Capital's Rating Upgrade Propels IGM Biosciences Into Immunology Limelight
Via Benzinga
Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
SPS Commerce Posts Upbeat Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
From IGM Biosciences, Inc.
Via GlobeNewswire
Morgan Stanley Reports Q4 Results, Joins Boeing, Alcoa And Other Big Stocks Moving Lower On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From IGM Biosciences, Inc.
Via GlobeNewswire
ZimVie Agrees To Sell Its Spine Business, Joins United States Steel, PGT Innovations And Other Big Stocks Moving Higher On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
IGM Biosciences Increases Focus On Autoimmune Diseases, Stops All Blood Cancer-Related Studies
Via Benzinga
IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences Announces Third Quarter 2023 Financial Results
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences to Present at Two Upcoming Investor Conferences
From IGM Biosciences, Inc.
Via GlobeNewswire
Why Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.